Directory

>

Kellye Daniels Ms Dabt

avatar

Kellye Daniels Ms Dabt

Vice President, Toxicology | Enanta Pharmaceuticals

Watertown, Massachusetts, United States

View contact details (it's free)

Kellye Daniels Ms Dabt

Summary

Kellye Daniels is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as the Vice President of Toxicology at Enanta Pharmaceuticals. With a Ph.D. in Neuroscience from the University of Florida, she has extensive experience in assay development, drug discovery, and toxicology. Kellye has held various leadership roles, overseeing complex nonclinical studies and regulatory submissions while managing cross-functional teams. Her career spans over two decades, with significant contributions to both scientific research and development services. Kellye is known for her strategic insights in toxicology and her ability to bridge the gap between science and business. She has worked with government and commercial clients, showcasing her versatility in both corporate and research environments. Her professional journey reflects a commitment to advancing biopharmaceutical innovation and improving patient outcomes.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Kellye Daniels Ms Dabt

Work Experience

company logo

Vice President, Toxicology at

Enanta Pharmaceuticals

January 2021 - Present

company logo

Director, Toxicology and Pathology Services at

Southern Research

August 2007 - February 2015

company logo

Director, Toxicogenomics at

Gene Logic

October 2003 - August 2007

company logo

Application Scientist at

Thermogenic Imaging

May 2002 - September 2003

💼

Program Director, Client Services at

Phase 1 Molecular Toxicology

September 2001 - April 2002

company logo

Collaboration Manager at

Rosetta Inpharmatics

March 2001 - August 2001

💼

Project Leader, Pharmacogenomics at

CuraGen Corporation

January 1998 - January 2000

Logos provided by Logo.dev

Kellye Daniels Ms Dabt

Education

University of Florida College of Medicine, Ph.D.

January 1992 - January 1997

University of South Florida, M.S.

January 1990 - January 1994

Florida State University, B.S.

January 1985 - January 1990

Frequently Asked Questions about Kellye Daniels Ms Dabt

What is Kellye Daniels Ms Dabt email address?

Kellye Daniels Ms Dabt's primary email address is ********@enanta.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Kellye Daniels Ms Dabt work for?

Kellye Daniels Ms Dabt is a Vice President, Toxicology at Enanta Pharmaceuticals, a company specializing in Commercial physical research.

Where Kellye Daniels Ms Dabt graduated from?

Kellye Daniels Ms Dabt holds a degree in Neuroscience from University of Florida College of Medicine.

How can I directly contact Kellye Daniels Ms Dabt?

To contact Kellye Daniels Ms Dabt directly, you can use the email address ********@enanta.com. Complete contact information is available upon registration with Muraena.

Who is Kellye Daniels Ms Dabt?

Kellye Daniels is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as the Vice President of Toxicology at Enanta Pharmaceuticals. With a Ph.D. in Neuroscience from the University of Florida, she has extensive experience in assay development, drug discovery, and toxicology. Kellye has held various leadership roles, overseeing complex nonclinical studies and regulatory submissions while managing cross-functional teams. Her career spans over two decades, with significant contributions to both scientific research and development services. Kellye is known for her strategic insights in toxicology and her ability to bridge the gap between science and business. She has worked with government and commercial clients, showcasing her versatility in both corporate and research environments. Her professional journey reflects a commitment to advancing biopharmaceutical innovation and improving patient outcomes.

Kellye`s contact details

mail

********@enanta.com

Colleagues

avatar
Scott Mitchell

Vice President of Chemistry at Enanta Pharmaceuticals

Paul Mellett

Chief Financial Officer

avatar
George Wu

Vice President, CMC

avatar
Brendan Luu

Chief Business Officer

avatar
Tara Kieffer

Chief Product Strategy Officer

avatar
Lijuan Jiang

Vice President, DMPK & Bioanalysis

avatar
Scott Rottinghaus

Chief Medical Officer

Kathleen Drabik

Executive Director, Contracts Administration

avatar
Katie Capps Cpa

Executive Director of Accounting, Controller

avatar
Lijuan Jiang

Vice President of DMPK and Bioanalysis

View Contact details (it's free)
Request Profile Removal